We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HLN:LSEHaleon PLC Analysis

Data as of 2026-06-12 - not real-time

£336.80

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical signals show a mixed picture: the 20‑day SMA (≈336) trails the 50‑day (≈344) and 200‑day (≈361) averages, indicating a long‑term bearish trajectory, while the MACD (line = ‑2.66, signal = ‑3.83) and a positive histogram suggest a short‑term bullish push. The RSI sits at 49.4, hovering just below the neutral 50 mark, and volume is on an upward trend, but the 30‑day volatility of 23.7% and an “Extreme Greed” sentiment index (89.09) signal heightened market risk.
Valuation and fundamentals show a nuanced stance: the current P/E of 17.7 is well below the industry average of 24.8, and the forward P/E falls to 14.9, suggesting value appeal, yet the discounted‑cash‑flow fair value (≈130) is dramatically lower than the present price (≈337), flagging a potential over‑extension. The dividend yield of 2.13% with a 36.8% payout ratio is sustainable, and the profit margin (15.1%) and ROE (10.3%) remain respectable despite a modest revenue growth of 0.6% and a debt‑to‑equity ratio of 52%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish SMA hierarchy and high 30‑day volatility
  • Positive MACD crossover but limited upside
  • Sustainable dividend offsetting market risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued P/E relative to industry
  • Strong oral‑health segment growth reported
  • Stable cash flow and modest debt load

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent dividend and payout sustainability
  • Broad international footprint reducing single‑region risk
  • Long‑term demand for consumer health products

Key Metrics & Analysis

Financial Health

Revenue Growth0.60%
Profit Margin15.11%
P/E Ratio17.7
ROE10.27%
ROA4.67%
Debt/Equity52.37
P/B Ratio1.8
Op. Cash Flow£2.6B
Free Cash Flow£1.4B
Industry P/E24.8

Technical Analysis

TrendBearish
RSI49.4
Support£317.80
Resistance£346.70
MA 20£335.88
MA 50£344.46
MA 200£361.38
MACDBullish
VolumeIncreasing
Fear & Greed Index89.09

Valuation

Fair Value£129.82
Target Price£417.47
Upside/Downside23.95%
GradeOvervalued
TypeBlend
Dividend Yield2.13%

Risk Assessment

Beta-0.18
Volatility23.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.